Keyword: Andrew Badrot

Chemistry & Life Sciences

The Impact of Covid-19 on the Pharmaceutical Industry

31.08.2020 -

Andrew Badrot, CEO of C2 Pharma and a close observer of pharma industry trends, analyzes the current situation and how this pandemic may kick of changes in the pharma...

Plant Construction & Process Technology

Double Risk with an Upgrade

31.10.2013 - Trial And Error - Despite a 150-year history and an aggregate R&D expenditure of $150 billion per year, innovation in the modern pharmaceutical industry is essentially still based...


The Future of Pharma

11.04.2013 - The Rise Of Generics - In 2011, CMS Pharma was invited to take part in a conference in Mumbai to discuss the emergence of "supergenerics," a new form of generic drugs with improved...